Arcadia Biosciences, Inc. (RKDA) › Cash & EquivalentsArcadia Biosciences, Inc. (RKDA) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2013-12-31: $2.83M2014-12-31: $16.57M2015-12-31: $23.97M2016-12-31: $2.01M2017-12-31: $9.12M2018-12-31: $12.00M2019-12-31: $8.42M2020-12-31: $14.04M2021-12-31: $28.68M2022-12-31: $20.64M2023-12-31: $6.52M2024-12-31: $4.24M2025-12-31: $259.0K$259.0K2013-12-31Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$259.0K-93.9%2026-03-26Balance as of period end2024-12-31$4.24M-34.9%2026-03-26Balance as of period end2023-12-31$6.52M-68.4%2025-03-25Balance as of period end2022-12-31$20.64M-28.0%2024-03-28Balance as of period end2021-12-31$28.68M+104.3%2023-03-30Balance as of period end2020-12-31$14.04M+66.8%2022-03-31Balance as of period end2019-12-31$8.42M-29.8%2021-03-31Balance as of period end2018-12-31$12.00M+31.5%2020-03-25Balance as of period end2017-12-31$9.12M+353.3%2019-04-01Balance as of period end2016-12-31$2.01M-91.6%2019-04-01Balance as of period end2015-12-31$23.97M+44.7%2018-03-20Balance as of period end2014-12-31$16.57M+484.5%2017-03-08Balance as of period end2013-12-31$2.83M—2016-03-08Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)